GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:MDGL

Madrigal Pharmaceuticals, Inc. Stock Insider Trading

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$212.04
-10.22 (-4.60%)
At Close: Apr 19, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Apr 08, 2024 Buy 2 676 Taub Rebecca Common Stock
Apr 08, 2024 Sell 224 Taub Rebecca Common Stock
Apr 08, 2024 Sell 945 Taub Rebecca Common Stock
Apr 08, 2024 Sell 300 Taub Rebecca Common Stock
Apr 08, 2024 Sell 600 Taub Rebecca Common Stock
Apr 08, 2024 Sell 407 Taub Rebecca Common Stock
Apr 08, 2024 Sell 200 Taub Rebecca Common Stock
Apr 08, 2024 Sell 2 676 Taub Rebecca Stock Option (Right to Buy)
Apr 08, 2024 Buy 26 270 Friedman Paul A Common Stock
Apr 08, 2024 Sell 1 441 Friedman Paul A Common Stock
Apr 08, 2024 Sell 3 730 Friedman Paul A Common Stock
Apr 08, 2024 Sell 26 270 Friedman Paul A Stock Option (Right to Buy)
Apr 08, 2024 Sell 5 663 Friedman Paul A Common Stock
Apr 08, 2024 Sell 2 078 Friedman Paul A Common Stock
Apr 08, 2024 Sell 5 028 Friedman Paul A Common Stock
Apr 08, 2024 Sell 3 464 Friedman Paul A Common Stock
Apr 08, 2024 Sell 4 866 Friedman Paul A Common Stock
Apr 05, 2024 Buy 27 506 Taub Rebecca Common Stock
Apr 05, 2024 Sell 1 643 Taub Rebecca Common Stock
Apr 05, 2024 Sell 700 Taub Rebecca Common Stock
Apr 05, 2024 Sell 8 817 Taub Rebecca Common Stock
Apr 05, 2024 Sell 8 989 Taub Rebecca Common Stock
Apr 05, 2024 Sell 2 079 Taub Rebecca Common Stock
Apr 05, 2024 Sell 5 278 Taub Rebecca Common Stock
Apr 05, 2024 Sell 27 506 Taub Rebecca Stock Option (Right to Buy)
Apr 05, 2024 Sell 27 613 Friedman Paul A Stock Option (Right to Buy)
Apr 05, 2024 Buy 27 613 Friedman Paul A Common Stock
Apr 05, 2024 Sell 1 420 Friedman Paul A Common Stock
Apr 05, 2024 Sell 612 Friedman Paul A Common Stock
Apr 05, 2024 Sell 6 679 Friedman Paul A Common Stock
Apr 05, 2024 Sell 9 264 Friedman Paul A Common Stock
Apr 05, 2024 Sell 3 966 Friedman Paul A Common Stock
Apr 05, 2024 Sell 5 228 Friedman Paul A Common Stock
Apr 05, 2024 Sell 444 Friedman Paul A Common Stock
Apr 04, 2024 Buy 18 537 Taub Rebecca Common Stock
Apr 04, 2024 Sell 4 200 Taub Rebecca Common Stock
Apr 04, 2024 Sell 5 619 Taub Rebecca Common Stock
Apr 04, 2024 Sell 3 085 Taub Rebecca Common Stock
Apr 04, 2024 Sell 435 Taub Rebecca Common Stock
Apr 04, 2024 Sell 2 734 Taub Rebecca Common Stock
Apr 04, 2024 Sell 1 653 Taub Rebecca Common Stock
Apr 04, 2024 Sell 711 Taub Rebecca Common Stock
Apr 04, 2024 Sell 100 Taub Rebecca Common Stock
Apr 04, 2024 Sell 18 537 Taub Rebecca Stock Option (Right to Buy)
Apr 04, 2024 Sell 18 710 Friedman Paul A Stock Option (Right to Buy)
Apr 04, 2024 Buy 18 710 Friedman Paul A Common Stock
Apr 04, 2024 Sell 6 273 Friedman Paul A Common Stock
Apr 04, 2024 Sell 5 299 Friedman Paul A Common Stock
Apr 04, 2024 Sell 1 467 Friedman Paul A Common Stock
Apr 04, 2024 Sell 627 Friedman Paul A Common Stock
Apr 04, 2024 Sell 2 549 Friedman Paul A Common Stock
Apr 04, 2024 Sell 1 558 Friedman Paul A Common Stock
Apr 04, 2024 Sell 737 Friedman Paul A Common Stock
Apr 04, 2024 Sell 200 Friedman Paul A Common Stock
Apr 03, 2024 Buy 27 845 Taub Rebecca Common Stock
Apr 03, 2024 Sell 135 Taub Rebecca Common Stock
Apr 03, 2024 Sell 2 634 Taub Rebecca Common Stock
Apr 03, 2024 Sell 4 070 Taub Rebecca Common Stock
Apr 03, 2024 Sell 18 917 Taub Rebecca Common Stock
Apr 03, 2024 Sell 2 089 Taub Rebecca Common Stock
Apr 03, 2024 Sell 27 845 Taub Rebecca Stock Option (Right to Buy)
Apr 03, 2024 Sell 27 407 Friedman Paul A Stock Option (Right to Buy)
Apr 03, 2024 Buy 27 407 Friedman Paul A Common Stock
Apr 03, 2024 Sell 185 Friedman Paul A Common Stock
Apr 03, 2024 Sell 2 294 Friedman Paul A Common Stock
Apr 03, 2024 Sell 4 301 Friedman Paul A Common Stock
Apr 03, 2024 Sell 18 806 Friedman Paul A Common Stock
Apr 03, 2024 Sell 1 821 Friedman Paul A Common Stock
Apr 02, 2024 Buy 11 212 Bate Kenneth Common Stock
Apr 02, 2024 Sell 1 217 Bate Kenneth Common Stock
Apr 02, 2024 Sell 7 048 Bate Kenneth Common Stock
Apr 02, 2024 Sell 2 080 Bate Kenneth Common Stock
Apr 02, 2024 Sell 567 Bate Kenneth Common Stock
Apr 02, 2024 Sell 100 Bate Kenneth Common Stock
Apr 02, 2024 Sell 193 Bate Kenneth Common Stock
Apr 01, 2024 Buy 6 000 Levy Richard S Common Stock
Apr 01, 2024 Sell 4 387 Levy Richard S Common Stock
Apr 01, 2024 Buy 5 000 Levy Richard S Common Stock
Apr 01, 2024 Sell 5 000 Levy Richard S Stock Option (Right to Buy)
Apr 01, 2024 Sell 3 900 Levy Richard S Common Stock
Apr 01, 2024 Sell 1 600 Levy Richard S Common Stock
Apr 01, 2024 Sell 100 Levy Richard S Common Stock
Apr 01, 2024 Sell 713 Levy Richard S Common Stock
Apr 01, 2024 Sell 300 Levy Richard S Common Stock
Apr 01, 2024 Sell 6 000 Levy Richard S Stock Option (Right to Buy)
Apr 01, 2024 Buy 1 277 Bate Kenneth Common Stock
Apr 01, 2024 Buy 10 000 Bate Kenneth Common Stock
Apr 01, 2024 Sell 6 698 Bate Kenneth Common Stock
Apr 01, 2024 Sell 1 277 Bate Kenneth Stock Option (Right to Buy)
Apr 01, 2024 Buy 10 000 Bate Kenneth Common Stock
Apr 01, 2024 Sell 10 000 Bate Kenneth Stock Option (Right to Buy)
Apr 01, 2024 Sell 7 411 Bate Kenneth Common Stock
Apr 01, 2024 Sell 2 790 Bate Kenneth Common Stock
Apr 01, 2024 Sell 2 104 Bate Kenneth Common Stock
Apr 01, 2024 Sell 200 Bate Kenneth Common Stock
Apr 01, 2024 Sell 841 Bate Kenneth Common Stock
Apr 01, 2024 Sell 143 Bate Kenneth Common Stock
Apr 01, 2024 Sell 116 Bate Kenneth Common Stock
Apr 01, 2024 Sell 700 Bate Kenneth Common Stock
Apr 01, 2024 Sell 274 Bate Kenneth Common Stock
JSON CSV
INSIDER POWER
-30.617
Last 100 transactions
Buy: 220 053 | Sell: 418 887 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be negative at a ratio of -30.617.

In total, the insiders bought 220 053 and sold 418 887 MDGL shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals. Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745,... MDGL Profile

Golden Star

Ticker Date Change Price
DOOR Apr 17 0.0305% $131.35
LNG Apr 17 3.29% $156.81
FCN Apr 16 1.75% $207.62
ELV Apr 16 4.82% $506.97
FTSL Apr 16 0.217% $46.08
AKR Apr 05 3.15% $16.53
ITCI Apr 05 5.74% $68.44
SARK Mar 28 18.79% $26.88
SON Mar 26 0.83% $56.64
ARCC Mar 25 2.34% $20.12
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT